Haloperidol for Delirium in Adult Critically Ill Patients

Clinical trial NCT03628391 · TERMINATED

Trial details

NCT number: NCT03628391
Sponsor: Erasmus Medical Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Delirium Critical Illness Intensive Care Psychosis Cognitive Impairment Cognitive Decline

Start date: 2018-02-22
Primary completion: 2020-02-03
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.